243 related articles for article (PubMed ID: 26577427)
1. Creating and using real-world evidence to answer questions about clinical effectiveness.
de Lusignan S; Crawford L; Munro N
J Innov Health Inform; 2015 Nov; 22(3):368-73. PubMed ID: 26577427
[TBL] [Abstract][Full Text] [Related]
2. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
Webster J; Smith BD
Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
[TBL] [Abstract][Full Text] [Related]
3. Translational hurdles with cannabis medicines.
Graham M; Lucas CJ; Schneider J; Martin JH; Hall W
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1325-1330. PubMed ID: 32281186
[TBL] [Abstract][Full Text] [Related]
4. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
5. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
6. Making Clinical Practice Guidelines Pragmatic: How Big Data and Real World Evidence Can Close the Gap.
Chew SY; Koh MS; Loo CM; Thumboo J; Shantakumar S; Matchar DB
Ann Acad Med Singap; 2018 Dec; 47(12):523-527. PubMed ID: 30636269
[TBL] [Abstract][Full Text] [Related]
7. Real-World Evidence: Useful in the Real World of US Payer Decision Making? How? When? And What Studies?
Malone DC; Brown M; Hurwitz JT; Peters L; Graff JS
Value Health; 2018 Mar; 21(3):326-333. PubMed ID: 29566840
[TBL] [Abstract][Full Text] [Related]
8. Emerging opportunities to harness real world data: An introduction to data sources, concepts, and applications.
O'Leary CP; Cavender MA
Diabetes Obes Metab; 2020 Apr; 22 Suppl 3():3-12. PubMed ID: 32250526
[TBL] [Abstract][Full Text] [Related]
9. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
Orsini LS; Berger M; Crown W; Daniel G; Eichler HG; Goettsch W; Graff J; Guerino J; Jonsson P; Lederer NM; Monz B; Mullins CD; Schneeweiss S; Brunt DV; Wang SV; Willke RJ
Value Health; 2020 Sep; 23(9):1128-1136. PubMed ID: 32940229
[TBL] [Abstract][Full Text] [Related]
10. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S
F1000Res; 2018; 7():111. PubMed ID: 30026923
[TBL] [Abstract][Full Text] [Related]
11. Replication of Randomized, Controlled Trials Using Real-World Data: What Could Go Wrong?
Thompson D
Value Health; 2021 Jan; 24(1):112-115. PubMed ID: 33431143
[TBL] [Abstract][Full Text] [Related]
12. Proceed with Caution When Using Real World Data and Real World Evidence.
Kim HS; Kim JH
J Korean Med Sci; 2019 Jan; 34(4):e28. PubMed ID: 30686950
[TBL] [Abstract][Full Text] [Related]
13. The present and future scope of real-world evidence research in diabetes: What questions can and cannot be answered and what might be possible in the future?
Zaccardi F; Davies MJ; Khunti K
Diabetes Obes Metab; 2020 Apr; 22 Suppl 3():21-34. PubMed ID: 32250528
[TBL] [Abstract][Full Text] [Related]
14. Improving transparency to build trust in real-world secondary data studies for hypothesis testing-Why, what, and how: recommendations and a road map from the real-world evidence transparency initiative.
Orsini LS; Monz B; Mullins CD; Van Brunt D; Daniel G; Eichler HG; Graff J; Guerino J; Berger M; Lederer NM; Jonsson P; Schneeweiss S; Wang SV; Crown W; Goettsch W; Willke RJ
Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1504-1513. PubMed ID: 32924243
[TBL] [Abstract][Full Text] [Related]
15. Use of Structured Template and Reporting Tool for Real-World Evidence for Critical Appraisal of the Quality of Reporting of Real-World Evidence Studies: A Systematic Review.
Khambholja K; Gehani M
Value Health; 2023 Mar; 26(3):427-434. PubMed ID: 36210293
[TBL] [Abstract][Full Text] [Related]
16. [Real-world evidence : Benefits and limitations in multiple sclerosis research].
Ziemssen T; Rothenbacher D; Kuhle J; Berger T
Nervenarzt; 2017 Oct; 88(10):1153-1158. PubMed ID: 28776214
[TBL] [Abstract][Full Text] [Related]
17. Use of real-world data and evidence for medical devices: a qualitative study of key informant interviews.
Polisena J; Jayaraman G
Int J Technol Assess Health Care; 2020 Dec; 36(6):579-584. PubMed ID: 33161916
[TBL] [Abstract][Full Text] [Related]
18. Real-World Evidence: A Primer.
Dang A
Pharmaceut Med; 2023 Jan; 37(1):25-36. PubMed ID: 36604368
[TBL] [Abstract][Full Text] [Related]
19. Strengths and weaknesses of 'real-world' studies involving non-vitamin K antagonist oral anticoagulants.
Camm AJ; Fox KAA
Open Heart; 2018; 5(1):e000788. PubMed ID: 29713485
[TBL] [Abstract][Full Text] [Related]
20. Using routine data to complement and enhance the results of randomised controlled trials.
Lewsey JD; Leyland AH; Murray GD; Boddy FA
Health Technol Assess; 2000; 4(22):1-55. PubMed ID: 11074392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
